These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


576 related items for PubMed ID: 8887381

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [International Agency for Research on Cancer Monographs (IARC)].
    Terracini B.
    G Ital Med Lav Ergon; 2008; 30(1):83; author reply 86-7. PubMed ID: 18700682
    [No Abstract] [Full Text] [Related]

  • 6. Current status of the Gene-Tox Program.
    Auletta AE, Kier LD, Mitchell AD.
    Prog Clin Biol Res; 1990; 340D():273-81. PubMed ID: 2371300
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Program of the International Center for Cancer Research: Epidemiological approach].
    Higginson J.
    Bull Cancer; 1975; 62(2):137-50. PubMed ID: 1218272
    [Abstract] [Full Text] [Related]

  • 9. [The International Agency for Research on Cancer (IARC) evaluations: the way they are conducted and their implications].
    Soleo L.
    G Ital Med Lav Ergon; 2008; 30(1):85; author reply 86-7. PubMed ID: 18705063
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Identification of human carcinogenic risks in IARC monographs].
    Vainio H, Wilbourn JD, Sasco AJ, Partensky C, Gaudin N, Heseltine E, Eragne I.
    Bull Cancer; 1995; 82(5):339-48. PubMed ID: 7626841
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC.
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract] [Full Text] [Related]

  • 17. [Decree 626/94, section VII "Protection from carcinogenic agents": comparison of agents tested for evidence of carcinogenicity by the EEC and IARC].
    Fondelli MC, Seniori Costantini A.
    Med Lav; 1997; 88(5):356-73. PubMed ID: 9489300
    [Abstract] [Full Text] [Related]

  • 18. The IARC october 2009 evaluation of benzene carcinogenicity was incomplete and needs to be reconsidered.
    Infante PF.
    Am J Ind Med; 2011 Feb; 54(2):157-64. PubMed ID: 21259299
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. False positives in cancer epidemiology.
    McLaughlin JK, Tarone RE.
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):11-5. PubMed ID: 23118145
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.